Linear ubiquitin chains whose very existence once was debated, now are known to play a critical role in an inflammatory disease, thanks to the discovery of an enzyme. David Komander’s group from the LMB are amongst a group of scientists researching the enzymes of the ubiquitin system, which has already shown how mutations in the […]
LMB In The News
Cell scientist to watch – Madeline Lancaster
Madeline Lancaster, group leader in the LMB’s Cell Biology Division, is interviewed by the Journal of Cell Science and describes her impetus to pursue a career in science, discusses starting her own lab at the LMB and talks about her current research. More…
HIV Research Breakthroughs 2016
Medical Daily includes work by the LMB’s Leo James’s group and University College London on improving antiviral drugs as one of its HIV research breakthroughs of 2016. More…
New microscope lens: top ten breakthroughs
Work by MRC funded Gail McConnell and LMB Emeritus, Brad Amos and colleagues at the University of Strathclyde have been selected for Physics World’s Top Ten Breakthroughs of 2016, for creating a new microscope lens that offers the unique combination of a large field of view with high resolution. Called a mesolens, the device allows […]
Richard Pannell “wins science ‘Oscar’ for his life’s work”
The Haverhill Echo celebrates local resident Richard Pannell’s MRC Lifetime Achievement CEO Award. Richard, who was nominated by his current supervisor, Andrew McKenzie, has worked at the LMB since 1980. More…
Master of Trinity’s Bicycle worth up to $1 billion
Bicycle Therapeutics, the Cambridge biotech company, has done a collaboration deal with AstraZeneca which puts it in line for up to $1 billion. Bicycle Therapeutics’ unique intellectual property is based on the work initiated at the MRC Laboratory of Molecular Biology in Cambridge by the scientific founders of the company, Sir Gregory Winter (Master of […]